[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341193-105":59,"doc-detail-341193-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","mkln1-as-promotes-pancreatic-cancer-progression-as-a-crucial-downstream-mediator-of-hif-1-through-mir-185-5ptead1-pathway","MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway","","Pancreatic ductal adenocarcinomas (PDAC) develop under profound hypoxia that drives malignant behaviors including proliferation, migration, and therapy resistance. The study establishes that the hypoxia-inducible long noncoding RNA lncRNA MKLN1-AS is controlled by HIF-1α and is elevated in human PDAC, correlating with worse outcomes. HIF-1α regulates MKLN1-AS via a hypoxia response element in its promoter, and MKLN1-AS functions as a competitive endogenous RNA binding miR-185-5p to modulate TEAD1, thereby promoting PDAC progression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mkln1-as-promotes-pancreatic-cancer-progression-as-a-crucial-downstream-mediator-of-hif-1-through-mir-185-5ptead1-pathway/341193/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mkln1-as-promotes-pancreatic-cancer-progression-as-a-crucial-downstream-mediator-of-hif-1-through-mir-185-5ptead1-pathway/341193.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does hypoxia play in PDAC progression?","Question",{"text":113,"@type":114},"The document states that PDAC hypoxia regulates cancer cell behaviors such as proliferation, migration, and resistance to therapies, and contributes to poor prognosis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is MKLN1-AS regulated in this research?",{"text":118,"@type":114},"MKLN1-AS is reported to be upregulated by hypoxia and controlled by HIF-1α, which directly binds a hypoxia response element in the MKLN1-AS promoter region.",{"name":120,"@type":111,"acceptedAnswer":121},"How does MKLN1-AS influence TEAD1 and tumor growth?",{"text":122,"@type":114},"MKLN1-AS acts as a competitive endogenous RNA by binding miR-185-5p, resulting in regulation of TEAD1 expression and promotion of PDAC cell proliferation, migration, and tumor growth.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341193,1790462898,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Cell Biol Toxicol (2024) 40:30  \n[https://doi.org/10.1007/s10565-024-09863-8](https://doi.org/10.1007/s10565-024-09863-8)  \nMKLN1‑AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF‑1α through miR‑185‑5p/TEAD1 pathway  \nJiayu Chen · Lei Li · Yongpu Feng · Yating Zhao ·  \nFengyuan Sun · Xianzhu Zhou · Du Yiqi ·  \nZhaoshen Li · Fanyang Kong · Xiangyu Kong  \nReceived: 15 November 2023 / Accepted: 25 March 2024 / Published online: 13 May 2024 © The Author(s) 2024  \nAbstract In pancreatic ductal adenocarcinomas (PDAC), profound hypoxia plays key roles in regulating cancer cell behavior, including proliferation, migration, and resistance to therapies. The initial part of this research highlights the important role played by long noncoding RNA (lncRNA) MKLN1-AS, which is controlled by hypoxia-inducible factor-1 alpha (HIF-1α), in the progression of PDAC. Human samples of PDAC showed a notable increase in MKLN1-AS expression, which was linked to a worse outcome. Forced expression of MKLN1-AS  \n\n| Jiayu Chen, Lei Li, Yongpu Feng, Yating Zhao, Fengyuan Sun, and Xianzhu Zhou contributed equally to this work. |\n| --- |\n| Xiangyu Kong is the handle correspondence author at all stages of refereeing, publication, and post-publication. |\n| Supplementary Information The online version contains supplementary material available at [https://doi](https://doi). org/10.1007/s10565-024-09863-8. |\n\nJ. Chen · Y. Feng · Y. Zhao · F. Sun · X. Zhou · Du. Yiqi (*) · Z. Li (*)  \nDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai 200433, China  \ne-mail: [duyiqi@hotmail.com](duyiqi@hotmail.com)  \nZ. Li  \ne-mail: [zhsl@vip.163.com](zhsl@vip.163.com)  \nJ. Chen · F. Sun · X. Zhou · F. Kong (*) Shanghai Institute of Pancreatic Diseases,  \nShanghai 200433, China  \n[e-mail: kfy8195288@163.com](e-mail: kfy8195288@163.com)  \ngreatly reduced the inhibitory impact on the growth and spread of PDAC cells caused by HIF-1α depletion. Experiments on mechanisms showed that HIF-1α influences the expression of MKLN1-AS by directly attaching to a hypoxia response element in the promoter region of MKLN1-AS.MKLN1-AS acts as a competitive endogenous RNA (ceRNA) by binding to miR-185-5p, resulting in the regulation of TEAD1 expression and promoting cell proliferation, migration, and tumor growth. TEAD1 subsequently enhances the development of PDAC. Our study results suggest that MKLN1-AS could serve asa promising target for treatment and a valuable indicator for predicting outcomes in PDAC. PDAC is associated with low oxygen levels, and the long noncoding RNA MKLN1-AS interacts with TEAD1 in this context.  \nJ. Chen · Y. Zhao · F. Sun · X. Kong (*)  \nNational key laboratory of Immunity and inflammation, Naval Medical University, Shanghai 200433, China  \ne-mail: [xiangyukong185@hotmail.com](xiangyukong185@hotmail.com)  \nL. Li  \nDigestive Endoscopy Center, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200433, China  \nKeywords PDAC · hypoxia · lncRNA · MKLN1-AS · TEAD1  \nIntroduction  \nPancreatic cancer, holding the seventh position in cancer-related deaths, stands as one of the deadliest human cancers (Siegel et al. 2022) . Pancreatic ductaladenocarcinoma (PDAC) is the most common typeof pancreatic cancer, representing 90% of cases (Park et al. 2021) . The poor prognosis of PDAC has been attributed to a variety of factors, including challenges in early detection and resistance to drugs (Connor and Gallinger 2022; Cai et al. 2021) . Currently, available effective therapeutics against PDAC remain limited. Thus, the investigation of targeted molecular therapies is urgently needed to improve outcomes of PDAC.  \nThe hypoxic tumor microenvironment is a prevalent characteristic of PDAC, that contributes to tumor progression and negatively impacts on prognosis (Tao et al. 2021) . Uncontrolled tumor proliferation and fibrosis formation result in intratumoral necrosis and insufficient oxygen supp","cbCaiosdtczRhmp6","https://ap.wps.com/l/cbCaiosdtczRhmp6","pdf",9391053,"English","# Introduction\n## Hypoxia and HIF-1α in PDAC\n## Long noncoding RNAs and HIF-1α signaling\n## Rationale and study aims","[{\"question\":\"What role does hypoxia play in PDAC progression?\",\"answer\":\"The document states that PDAC hypoxia regulates cancer cell behaviors such as proliferation, migration, and resistance to therapies, and contributes to poor prognosis.\"},{\"question\":\"How is MKLN1-AS regulated in this research?\",\"answer\":\"MKLN1-AS is reported to be upregulated by hypoxia and controlled by HIF-1α, which directly binds a hypoxia response element in the MKLN1-AS promoter region.\"},{\"question\":\"How does MKLN1-AS influence TEAD1 and tumor growth?\",\"answer\":\"MKLN1-AS acts as a competitive endogenous RNA by binding miR-185-5p, resulting in regulation of TEAD1 expression and promotion of PDAC cell proliferation, migration, and tumor growth.\"}]","MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway | PDF",1790040831,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5695c05d82e700d75231440caa6ca26.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9433de0b6e6719308007f187ff142c1b.webp",982,1322,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebcd37baa046161d0b1e623d10b7ede5.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64412a585a9db5c7473fc75511ec7e18.webp",980,1319]